-
Rotigotine Antidepressant Effects in Depression Models
2026-09-15
This 2006 study evaluated Rotigotine across complementary rat models of anxiety, behavioral despair, learned helplessness, and depression-related hyperactivity. Its main contribution was showing antidepressant-like effects at lower doses while identifying increased locomotor activity at higher exposure as an important interpretive confound.
-
Baicalin Reopens Visual Plasticity in Adult Amblyopia
2026-09-15
A 2026 NeuroImage study found that baicalin reactivated ocular dominance plasticity and restored visual acuity in adult mice with amblyopia when combined with reverse suturing. Imaging, electrophysiology, molecular analysis, and pharmacological blockade linked the effect to reduced GABAergic inhibition in the visual cortex, while also defining important limits for translation to human treatment.
-
MST1/2 Integrate Macrophage Death Signals
2026-09-14
The reference study identifies MST1/2 cleavage as a flexible signaling node that links inflammatory stimuli and pathogen-specific macrophage death responses. Its comparison of apoptosis, pyroptosis, inflammasome activity, and bacterial infection provides a framework for interpreting DNA fragmentation readouts alongside pathway-specific markers.
-
Rotigotine and Bladder Control in Parkinson’s Disease
2026-09-14
This study shows that rotigotine alters bladder contraction patterns in a 6-hydroxydopamine rat model of Parkinson’s disease, with effects that depend strongly on administration route and dose. Its key contribution is linking broad dopaminergic agonism to lower urinary tract physiology, while also highlighting why acute intravenous and subcutaneous responses should not be treated as interchangeable.
-
Wnt-C59 PORCN Inhibitor Workflow Guide
2026-09-13
Wnt-C59 provides a precise way to test whether secreted Wnt ligands drive signaling, osteogenic differentiation, or tumor behavior. This workflow connects exosomal Wnt10a research with cancer biology while emphasizing controls, dosing logic, and troubleshooting.
-
MitMAB for Reliable Endocytosis Assays
2026-09-12
Learn how MitMAB (SKU B7620) can support controlled dynamin-dependent endocytosis experiments in intestinal organoid and cell-based workflows. This scenario-driven guide covers assay design, handling, viability controls, data interpretation, and practical product-selection criteria.
-
WAY-100635 Workflows for Pain and 5-HT1A Studies
2026-09-12
WAY-100635 enables receptor-specific testing of serotonergic contributions to pain, affect, and neuronal signaling. This workflow-focused guide shows how to pair binding, functional, behavioral, and molecular assays while avoiding solubility, vehicle, and interpretation errors.
-
Rotigotine: Designing Time-Aware PD Assays
2026-09-11
Rotigotine is a dopamine D2/D3 receptor agonist whose experimental value depends on more than receptor affinity. This guide develops a time-aware framework for Parkinson’s disease research, connecting continuous dopaminergic exposure, model selection, assay controls, and translational interpretation.
-
Diuron: From Photosynthesis to Renal Toxicology
2026-09-11
Diuron is more than a photosynthesis inhibitor: it is a useful model for connecting herbicide mechanism of action with kidney toxicology. This article presents an evidence-based framework for selecting endpoints, controlling exposure variables, and interpreting cross-domain assays.
-
Ciprofloxacin Hydrochloride Research Workflows
2026-09-10
Ciprofloxacin hydrochloride supports more than routine antibacterial testing: it can serve as a DNA-replication-inhibition benchmark, a comparator in antiparasitic screening, and a probe for immune and stress-response models. This practical guide connects mechanism, assay design, solution handling, and troubleshooting to improve reproducibility across cell, bacterial, and translational workflows.
-
ONX-0914 (PR-957) Experimental Workflow
2026-09-10
Build reproducible immunoproteasome experiments around ONX-0914 (PR-957), from LMP7-selective cytokine assays to mechanistic antiviral studies. The workflow emphasizes concentration control, orthogonal readouts, and careful separation of established evidence from application-focused recommendations.
-
iRhom2 in Olfaction: OR Regulation and Adaptation
2026-09-09
Azzopardi and colleagues identify iRhom2 as an olfactory sensory neuron factor that links odorant receptor activity with transcriptional adaptation. Using knockout mice, transcriptomics, spatial validation, and a receptor stimulation model, the study supports an iRhom2/ADAM17-associated pathway while also defining important limits on causal interpretation.
-
Acetoacetic Acid Sodium Salt in Cell Assays
2026-09-09
Learn how Acetoacetic acid sodium salt (SKU A9940) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing metabolic perturbation with assay failure. This scenario-based guide covers formulation, controls, protocol optimization, interpretation, and reagent selection using documented purity and solubility data.
-
Budesonide for Airway Inflammation Research
2026-09-08
Budesonide supports controlled asthma inflammation models, glucocorticoid-response studies, and membrane-permeability workflows. This guide connects practical cell-based assay design with IAM LC and LEKC insights to improve dose selection, interpretation, and troubleshooting in respiratory disease research.
-
Ionomycin Free Acid for FAK–TNBC Calcium Studies
2026-09-08
Ionomycin free acid provides a controlled way to examine calcium ion transport alongside the FAISL–FAK axis in triple-negative breast cancer research. This article translates the reference study into practical assay decisions while defining what calcium perturbation can—and cannot—demonstrate.